Synergistic anti-tumour effect of syk inhibitor and olaparib in squamous cell carcinoma: Roles of syk in EGFR signalling and PARP1 activation

Duen Yi Huang, Wei Yu Chen, Chi Long Chen, Nan Lin Wu, Wan Wan Lin

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Synergistic anti-tumour effect of syk inhibitor and olaparib in squamous cell carcinoma: Roles of syk in EGFR signalling and PARP1 activation'. Together they form a unique fingerprint.

Medicine & Life Sciences